Why Do Manufacturers Limit the Distribution of Certain Specialty Drugs?
August 20th 2013Some pharmaceutical manufacturers choose a limited distribution model for their specialty product so that they can ensure all standards of care and reporting associated with that therapy are upheld, noted Duane Barnes, senior vice president, consumer delivery, Prime Therapeutics, at the 2013 Armada Specialty Pharmacy Summit.
Aligning PBM Medical and Pharmacy Policies
August 6th 2013Prime Therapeutics projects that by 2017, the cost of specialty pharmaceuticals will be half the cost of all pharmacy claims. Therefore, noted Duane Barnes, senior vice president, consumer delivery at Prime Therapeutics, it is important for a PBM to align its medical and pharmacy policies.
Effective Utilization Management Programs for Specialty Pharmacies
July 25th 2013Specialty pharmacies can minimize "cost to treat" by identifying which specialty drugs have dose optimization opportunities, noted Michael Einodshofer, RPh, MBA, director of utilization management, Walgreens, at the 2013 PBMI Drug Benefit Conference.
Site-of-Care Optimization Under the Medical Benefit
June 15th 2013Michael Einodshofer, director, utilization management, Walgreens, describes how contractual methodologies and cost differences across various sites of service can influence how a specialty drug is reimbursed under the medical benefit.
Competition in the Specialty Pharmacy Game
May 16th 2013In this video from the 2013 Armada Specialty Pharmacy Summit in Las Vegas, Nevada, Adam J. Fein of Pembroke Consulting Inc and Drug Channels discusses the boom in new specialty pharmacy trade associations and describes the impact that competition amongst specialty pharmacy providers could have on the industry.